{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:28:04Z","timestamp":1786717684726,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Androl"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/1008-682x.179527","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:40:20Z","timestamp":1459471220000},"page":"520","source":"Crossref","is-referenced-by-count":37,"title":["Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer"],"prefix":"10.4103","volume":"18","author":[{"given":"Rong","family":"Na","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CarlyA","family":"Conran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deke","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SLilly","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CharlesB","family":"Brendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1008-682X.179527-1","first-page":"1388","volume-title":"Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group","author":"Zhou","year":"2016","journal-title":"Int J Cancer"},{"key":"key-10.4103\/1008-682X.179527-2","first-page":"981","volume-title":"Prostate-cancer mortality at 11 years of follow-up","author":"Schroder","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1008-682X.179527-3","doi-asserted-by":"crossref","unstructured":"Moyer VA; U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157: 120-34.","DOI":"10.7326\/0003-4819-157-2-201207170-00459"},{"key":"key-10.4103\/1008-682X.179527-4","first-page":"1143","volume-title":"Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence","author":"Hayes","year":"2014","journal-title":"JAMA"},{"key":"key-10.4103\/1008-682X.179527-5","first-page":"419","volume-title":"Early detection of prostate cancer: AUA guideline","author":"Carter","year":"2013","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.179527-6","first-page":"529","volume-title":"Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial","author":"Thompson","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/1008-682X.179527-7","first-page":"75","volume-title":"Impact of family history on prostate cancer mortality in white men undergoing prostate specific antigen based screening","author":"Liss","year":"2015","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.179527-8","first-page":"390","volume-title":"Prostate cancer risk prediction based on complete prostate cancer family history","author":"Albright","year":"2015","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.179527-9","first-page":"724","volume-title":"Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening","author":"Vertosick","year":"2014","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.179527-10","first-page":"68","volume-title":"Familial risk and heritability of cancer among twins in Nordic countries","author":"Mucci","year":"2016","journal-title":"JAMA"},{"key":"key-10.4103\/1008-682X.179527-11","first-page":"1322","volume-title":"Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial","author":"Liss","year":"2015","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.179527-12","first-page":"1103","volume-title":"A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer","author":"Al","year":"2014","journal-title":"Nat Genet"},{"key":"key-10.4103\/1008-682X.179527-13","first-page":"1467","volume-title":"Prediction of individual genetic risk to prostate cancer using a polygenic score","author":"Szulkin","year":"2015","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.179527-14","first-page":"1121","volume-title":"Risk analysis of prostate cancer in PRACTICAL, a multinational consortium, using 25 known prostate cancer susceptibility loci","author":"Amin","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key-10.4103\/1008-682X.179527-15","first-page":"789","volume-title":"Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis","author":"Pashayan","year":"2015","journal-title":"Genet Med"},{"key":"key-10.4103\/1008-682X.179527-16","first-page":"953","volume-title":"Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial","author":"Kader","year":"2012","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.179527-17","first-page":"125","volume-title":"Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up","author":"Andriole","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/1008-682X.179527-18","first-page":"910","volume-title":"Cumulative association of five genetic variants with prostate cancer","author":"Zheng","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1008-682X.179527-19","first-page":"2052","volume-title":"Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL consortium","author":"Kote-Jarai","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key-10.4103\/1008-682X.179527-20","first-page":"1565","volume-title":"Estimation of absolute risk for prostate cancer using genetic markers and family history","author":"Xu","year":"2009","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.179527-21","first-page":"363","volume-title":"Clinical utility of five genetic variants for predicting prostate cancer risk and mortality","author":"Salinas","year":"2009","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.179527-22","first-page":"1330","volume-title":"Replication of prostate cancer risk loci in a Japanese case-control association study","author":"Yamada","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/1008-682X.179527-23","first-page":"421","volume-title":"Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer","author":"Sun","year":"2011","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.179527-24","first-page":"21","volume-title":"Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study","author":"Aly","year":"2011","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.179527-25","first-page":"437","volume-title":"Common genetic variants in prostate cancer risk prediction - results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)","author":"Lindstrom","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key-10.4103\/1008-682X.179527-26","first-page":"471","volume-title":"Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men","author":"Klein","year":"2012","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.179527-27","first-page":"e46454","volume-title":"Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese","author":"Akamatsu","year":"2012","journal-title":"PLoS One"},{"key":"key-10.4103\/1008-682X.179527-28","first-page":"577","volume-title":"Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs","author":"Zheng","year":"2012","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.179527-29","first-page":"1651","volume-title":"Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer risk-associated SNPs","author":"Jiang","year":"2013","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.179527-30","first-page":"1623","volume-title":"Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men","author":"Na","year":"2013","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.179527-31","first-page":"1824","volume-title":"Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes","author":"Ren","year":"2013","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.179527-32","first-page":"549","volume-title":"Genetic predisposition to early recurrence in clinically localized prostate cancer","author":"Borque","year":"2013","journal-title":"BJU Int"},{"key":"key-10.4103\/1008-682X.179527-33","first-page":"365","volume-title":"Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?","author":"Butoescu","year":"2014","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.179527-34","first-page":"1184","volume-title":"A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng\/ml","author":"Nordstrom","year":"2014","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.179527-35","first-page":"223","volume-title":"Associations between iCOGS single nucleotide polymorphisms and upgrading in both surgical and active surveillance cohorts of men with prostate cancer","author":"Kearns","year":"2016","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.179527-36","first-page":"878","volume-title":"A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences","author":"Hoffmann","year":"2015","journal-title":"Cancer Discov"},{"key":"key-10.4103\/1008-682X.179527-37","first-page":"474","volume-title":"Known susceptibility SNPs for sporadic prostate cancer show a similar association with \"hereditary\" prostate cancer","author":"Cremers","year":"2015","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.179527-38","first-page":"1210","volume-title":"Generalizability of established prostate cancer risk variants in men of African ancestry","author":"Han","year":"2015","journal-title":"Int J Cancer"},{"key":"key-10.4103\/1008-682X.179527-39","first-page":"1667","volume-title":"Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study","author":"Gronberg","year":"2015","journal-title":"Lancet Oncol"}],"container-title":["Asian Journal of Andrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:27:20Z","timestamp":1786714040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1008-682X.179527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"alternative-id":["179527"],"URL":"https:\/\/doi.org\/10.4103\/1008-682x.179527","relation":{},"ISSN":["1008-682X"],"issn-type":[{"value":"1008-682X","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}